These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16169303)

  • 21. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced hypothyroidism accelerates the regression of liver fibrosis in rats.
    Bruck R; Weiss S; Traister A; Zvibel I; Aeed H; Halpern Z; Oren R
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2189-94. PubMed ID: 18031379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
    Younis N; Shaheen MA; Abdallah MH
    Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.
    Neef M; Ledermann M; Saegesser H; Schneider V; Widmer N; Decosterd LA; Rochat B; Reichen J
    J Hepatol; 2006 Jan; 44(1):167-75. PubMed ID: 16168515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
    Zhen MC; Wang Q; Huang XH; Cao LQ; Chen XL; Sun K; Liu YJ; Li W; Zhang LJ
    J Nutr Biochem; 2007 Dec; 18(12):795-805. PubMed ID: 17481882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY; Wang BE; Wang TL; Li XM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction.
    Schandalik R; Perucca E
    Drugs Exp Clin Res; 1994; 20(1):37-42. PubMed ID: 7924893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2.
    Di Sario A; Bendia E; Macarri G; Candelaresi C; Taffetani S; Marzioni M; Omenetti A; De Minicis S; Trozzi L; Benedetti A
    Dig Liver Dis; 2004 Nov; 36(11):744-51. PubMed ID: 15571005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin.
    Subudhi U; Das K; Paital B; Bhanja S; Chainy GB
    Chem Biol Interact; 2008 May; 173(2):105-14. PubMed ID: 18377885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
    Jiao K; Sun Q; Chen B; Li S; Lu J
    Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsian-tsao (Mesona procumbens Heml.) prevents against rat liver fibrosis induced by CCl(4) via inhibition of hepatic stellate cells activation.
    Shyu MH; Kao TC; Yen GC
    Food Chem Toxicol; 2008 Dec; 46(12):3707-13. PubMed ID: 18929613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis.
    Buzzelli G; Moscarella S; Giusti A; Duchini A; Marena C; Lampertico M
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):456-60. PubMed ID: 8225695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats.
    Pradeep K; Mohan CV; Gobianand K; Karthikeyan S
    Eur J Pharmacol; 2007 Apr; 560(2-3):110-6. PubMed ID: 17300777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of total flavonoids of Bidens pilosa L. (TFB) on animal liver injury and liver fibrosis.
    Yuan LP; Chen FH; Ling L; Dou PF; Bo H; Zhong MM; Xia LJ
    J Ethnopharmacol; 2008 Mar; 116(3):539-46. PubMed ID: 18313245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.
    Schandalik R; Gatti G; Perucca E
    Arzneimittelforschung; 1992 Jul; 42(7):964-8. PubMed ID: 1329780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.